bpc 157 for ulcerative colitis FDA panel backs compounded BPC-157, KPV peptides in win RFK Jr 🙋🏻‍♂️ Is the lack of

Is the lack of human data in BPC 157 a red flag?, , If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldnt bury itthey A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Another step forward: The FDA Pharmacy Compounding Advisory Committee voted 86 in favor of recommending BPC 157 for ulcerative colitis. FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them

SKU: 9592064593 · From centoria.fr